Richard M. Nowak

Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease

Personalized diagnosis in suspected myocardial infarction

Diagnostic Performance of High-Sensitivity Cardiac Troponin T Strategies and Clinical Variables in a Multisite US Cohort

Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction

N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department

Prognostic Utility of a Modified HEART Score in Chest Pain Patients in the Emergency Department

Multicenter Evaluation of a 0-Hour/1-Hour Algorithm in the Diagnosis of Myocardial Infarction With High-Sensitivity Cardiac Troponin T

Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations

The Use of Very Low Concentrations of High‐sensitivity Troponin T to Rule Out Acute Myocardial Infarction Using a Single Blood Test

Children and Adults With Frequent Hospitalizations for Asthma Exacerbation, 2012-2013: A Multicenter Observational Study

Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial

A Consensus Parameter for the Evaluation and Management of Angioedema in the Emergency Department

Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial

Abstract 13996: Does Copeptin Provide Additional Risk Stratification in Chest Pain Patients With a Mild Troponin Elevation?

Copeptin Helps in the Early Detection of Patients With Acute Myocardial Infarction

Atrial Fibrillation Impairs the Diagnostic Performance of Cardiac Natriuretic Peptides in Dyspneic Patients

Use of Procalcitonin for the Diagnosis of Pneumonia in Patients Presenting with a Chief Complaint of Dyspnoea: Results from the BACH (Biomarkers in Acute Heart Failure) Trial